No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
Precision BioSciences Analyst Ratings
Director's Bold Move: A Strategic Investment in Precision BioSciences
Precision BioSciences Reports Positive 2024 Financial Results
Precision Biosciences Shares Are Trading Lower After the Company Reported a Q4 EPS Miss.
Precision BioSciences | 10-K: FY2024 Annual Report